Tags

Type your tag names separated by a space and hit enter

[Nabiximols as a substitute for cannabis].
Ned Tijdschr Geneeskd. 2020 09 24; 164NT

Abstract

Cannabis addiction is worldwide one of the most prevalent addictions, without any effective pharmacotherapeutic options. Nabiximols spray, consisting of 2.7 mg tetrahydrocannabinol (THC) and 2.5 mg cannabidiol (CBD), could serve as an effective substitution therapy for cannabis addiction. Researchers reported that patients who were treated for 12 weeks with nabiximols significantly reduced the number of days on which they used cannabis (18.6 days less compared to placebo users; 95% CI: 3.5-33.7). There was no difference between groups regarding general health, the use of other substances, cannabis craving, withdrawal symptoms or achieving abstinence.

Authors+Show Affiliations

Amsterdam UMC, locatie AMC, ziekenhuisapotheek, Amsterdam. Contact: G. J.H. Dumont (g.j.dumont@amsterdamumc.nl).

Pub Type(s)

Journal Article

Language

dut

PubMed ID

33201625

Citation

Dumont, G J H.. "[Nabiximols as a Substitute for Cannabis]." Nederlands Tijdschrift Voor Geneeskunde, vol. 164, 2020.
Dumont GJH. [Nabiximols as a substitute for cannabis]. Ned Tijdschr Geneeskd. 2020;164.
Dumont, G. J. H. (2020). [Nabiximols as a substitute for cannabis]. Nederlands Tijdschrift Voor Geneeskunde, 164.
Dumont GJH. [Nabiximols as a Substitute for Cannabis]. Ned Tijdschr Geneeskd. 2020 09 24;164 PubMed PMID: 33201625.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Nabiximols as a substitute for cannabis]. A1 - Dumont,G J H, Y1 - 2020/09/24/ PY - 2020/11/17/entrez PY - 2020/11/18/pubmed PY - 2021/5/18/medline JF - Nederlands tijdschrift voor geneeskunde JO - Ned Tijdschr Geneeskd VL - 164 N2 - Cannabis addiction is worldwide one of the most prevalent addictions, without any effective pharmacotherapeutic options. Nabiximols spray, consisting of 2.7 mg tetrahydrocannabinol (THC) and 2.5 mg cannabidiol (CBD), could serve as an effective substitution therapy for cannabis addiction. Researchers reported that patients who were treated for 12 weeks with nabiximols significantly reduced the number of days on which they used cannabis (18.6 days less compared to placebo users; 95% CI: 3.5-33.7). There was no difference between groups regarding general health, the use of other substances, cannabis craving, withdrawal symptoms or achieving abstinence. SN - 1876-8784 UR - https://www.unboundmedicine.com/medline/citation/33201625/[Nabiximols_as_a_substitute_for_cannabis]_ L2 - https://medlineplus.gov/marijuana.html DB - PRIME DP - Unbound Medicine ER -